secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker DBVT CIK 0001613780
other material confidence high sentiment neutral materiality 0.60

DBV Technologies shareholders approve reverse split and ATM program at AGM

DBV Technologies S.A.

item 5.03item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-24-140531
form_type
8-K
ticker
DBVT
cik
0001613780
company_name
DBV Technologies S.A.
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:19.256761+00:00
generated_at
2026-06-01T21:09:57.013290+00:00
sec_items
["5.03", "5.07", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-24-140531
json_url
https://secwatch.observer/filing/0001193125-24-140531.json
markdown_url
https://secwatch.observer/filing/0001193125-24-140531.md
text_url
https://secwatch.observer/filing/0001193125-24-140531.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1613780/000119312524140531/0001193125-24-140531-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1613780/000119312524140531/d788664d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

2d22f774d7b1c8006fd56832ecd591b57ce99cf9

DBV Technologies S.A.: Amended Article 3 of the bylaws to change the registered office address (effective 2024-05-16).

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

25267a42ba549c17006e94c02bb44a6076085057

DBV Technologies S.A. shareholders approved The resolution approving the compensation policy for the Chief Executive Officer and Deputy Chief Executive Officer for the year ending December 31, 2024 at the 2024-05-16 meeting.

The resolution approving the compensation policy for the Chief Executive Officer and Deputy Chief Executive Officer for the year ending December 31, 2024, was approved, based on the following votes: Voted For Voted Against Vote Withheld 38,707,560 10,105,744 115,199

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

2be91415815b52e5874b851a19861c5be2d24426

DBV Technologies S.A. shareholders approved The resolution authorizing a reverse split of the Company's shares by allocation of one new share with a par value of €1 for ten (10) existing shares with a par value of €0.10 each and delegating powers to the Board of Directors for the purpose of implementing the reverse split at the 2024-05-16 meeting.

The resolution authorizing a reverse split of the Company's shares by allocation of one new share with a par value of €1 for ten (10) existing shares with a par value of €0.10 each and delegating powers to the Board of Directors for the purpose of implementing the reverse split was approved, based on the following votes: Voted For Voted Against Vote Withheld 46,556,628 2,345,690 26,185

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

2e887282e365dceb10544e2a2c6ebcca3a32745b

DBV Technologies S.A. shareholders approved The resolution renewing Ms. Adora Ndu as director at the 2024-05-16 meeting.

The resolution renewing Ms. Adora Ndu as director was approved, based on the following votes: Voted For Voted Against Vote Withheld 39,165,811 9,633,423 129,269

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

3137e0af6734bea9d2139f7c8f3ecbea2b1d18b1

DBV Technologies S.A. shareholders approved The resolution regarding the advisory opinion on the compensation of named executive officers other than the Chief Executive Officer at the 2024-05-16 meeting.

The resolution regarding the advisory opinion on the compensation of named executive officers other than the Chief Executive Officer was approved, based on the following votes: Voted For Voted Against Vote Withheld 38,737,226 10,045,250 146,027

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

3273615c6883979920e221c044c5090d82ce7d8e

DBV Technologies S.A. shareholders approved The resolution renewing Ms. Julie O’Neill, as director at the 2024-05-16 meeting.

The resolution renewing Ms. Julie O’Neill, as director was approved, based on the following votes: Voted For Voted Against Vote Withheld 39,248,276 9,635,652 44,575

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

34e2760ada715fcb504cf618519d816dc6e8c04e

DBV Technologies S.A. shareholders approved The resolution approving the compensation policy for the Directors for the year ending December 31, 2024 at the 2024-05-16 meeting.

The resolution approving the compensation policy for the Directors for the year ending December 31, 2024, was approved, based on the following votes: Voted For Voted Against Vote Withheld 38,706,847 10,101,653 120,003

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

350aa35f1c1c400a83a6e8700e888bb1a7262581

DBV Technologies S.A. shareholders approved The resolution renewing Ms. Danièle Guyot-Caparros, as director at the 2024-05-16 meeting.

The resolution renewing Ms. Danièle Guyot-Caparros, as director was approved, based on the following votes: Voted For Voted Against Vote Withheld 48,659,861 139,373 129,269

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

40dd5efbc85bfa57a0ee05ed3bf5864cab3635a0

DBV Technologies S.A. shareholders approved The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2023, to Mr. Daniel Tassé, Chief Executive Officer at the 2024-05-16 meeting.

The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2023, to Mr. Daniel Tassé, Chief Executive Officer was approved, based on the following votes: Voted For Voted Against Vote Withheld 38,730,052 10,080,616 117,835

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

ace40f4d985464bb1405492970449b4b3eea5211

DBV Technologies S.A. shareholders approved The resolution renewing Mr. Ravi M. Rao, as director at the 2024-05-16 meeting.

The resolution renewing Mr. Ravi M. Rao, as director was approved, based on the following votes: Voted For Voted Against Vote Withheld 39,165,671 9,633,296 129,536

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

adbdbebe384cfaa36e1f3d7185aff100149eced7

DBV Technologies S.A. shareholders approved The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2023, to Mr. Michel de Rosen, Chairman of the Board of Directors at the 2024-05-16 meeting.

The resolution approving the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2023, to Mr. Michel de Rosen, Chairman of the Board of Directors was approved, based on the following votes: Voted For Voted Against Vote Withheld 48,208,598 603,413 116,492

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

b9c501009563b677c0f3c44174ba977c96c36286

DBV Technologies S.A. shareholders approved The resolution approving the compensation policy for the Chairman of the Board of Directors for the year ending December 31, 2024 at the 2024-05-16 meeting.

The resolution approving the compensation policy for the Chairman of the Board of Directors for the year ending December 31, 2024, was approved, based on the following votes: Voted For Voted Against Vote Withheld 38,705,573 10,104,252 118,678

SEC 8-K Item 5.07 confidence 1.0 SEC evidence

Comparable filings

DCOM

Dime Commercial Bancshares name change effective; three executives amend employment agreements

Dime Community Bancshares, Inc. /NY/ June 1, 2026, 4:02 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.

Filing page SEC filing

AEIS

AEIS stockholders approve doubling of authorized shares to 140M and expansion of equity plan to 4.9M shares

ADVANCED ENERGY INDUSTRIES INC May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

the amendment increases the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares. The amendment became effective upon the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 7, 2026.

Filing page SEC filing

FBIN

Fortune Brands shareholders approve removal of supermajority voting, board declassification

Fortune Brands Innovations, Inc. May 7, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

On May 6, 2026, the Company filed with the Secretary of State of the State of Delaware an Amended and Restated Certificate of Incorporation, the form of which was included as Appendix B to the Company's definitive Proxy Statement.

Filing page SEC filing

RYZ

Ryerson stockholders approve 1.5M share increase in 2014 incentive plan; director Calhoun departs

Ryerson Holding Corp May 6, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

On April 30, 2026, at the Annual Meeting, upon the recommendation of the Board, the stockholders of the Company approved a proposal to amend and restate the Company’s Amended and Restated Certificate of Incorporation (the “Amended and Restated Charter”) to provide for the exculpation of certain of the Company’s officers in specific circumstances, as permitted by Delaware law.

Filing page SEC filing

CVNA

Carvana stockholders approve 5-for-1 stock split, adopt new 2026 incentive plan

CARVANA CO. May 6, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

At the Annual Meeting, the Company's stockholders approved an amendment (the "Amendment") to the Company's Amended and Restated Certificate of Incorporation to effect a five-for-one forward stock split of the Company's Class A common stock and Class B common stock (the "Stock Split") and to proportionately increase the number of authorized shares of Class A common stock and Class B common stock (the "Authorized Share Increase").

Filing page SEC filing

LEGT

Legato Merger Corp. III shareholders approve extension to August 8, 2026 for Einride business combination

Legato Merger Corp. III May 6, 2026, 7:59 PM ET other_material Items 2.03, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

As previously disclosed, on November 12, 2025, Legato Merger Corp. III, a Cayman Islands exempted company (the “Company”), Einride AB, a limited liability company formed under the laws of Sweden (“Einride”), and Einride Cayman Sub Limited, a Cayman Islands exempted company and a direct, wholly-owned subsidiary of Einride (“Merger Sub”), entered into a Business Combination Agreement (“BCA”). Pursuant to the BCA, the Company will merge with and into Merger Sub, with Merger Sub surviving the merger (“Merger”). As a result of the Merger, Merger Sub will continue as a direct, wholly-owned subsidiary of Einride, with the shareholders of the Company becoming shareholders of Einride. On May 5, 2026, the Company held an extraordinary general meeting (the “Meeting”) to approve the following resolutions: ● to resolve as a special resolution, that the Company’s amended and restated memorandum and articles of association as adopted by special resolution dated February 5, 2024 with effect from Febru

Filing page SEC filing

BSX

Boston Scientific stockholders approve charter amendments and ESPP share increase at 2026 annual meeting

BOSTON SCIENTIFIC CORP May 5, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

approved amendments (the “Charter Amendments”) to the Company’s Third Restated Certificate of Incorporation, as described in the Company’s definitive proxy statement for the Annual Meeting filed on March 18, 2026 (the “Proxy Statement”) to (a) eliminate supermajority voting provisions contained therein, as well as to eliminate certain inoperative provisions and implement other clarifying and correcting changes, and (b) provide for exculpation of certain of our officers in certain circumstances as permitted by Delaware law. The Charter Amendments became effective upon the filing of the Company’s Fourth Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 5, 2026.

Filing page SEC filing

SLXN

Silexion shareholders approve 50M share increase, expanded equity plan, and 1-for-10 reverse split

Silexion Therapeutics Corp May 5, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.03, 5.07, 9.01 same event type: other_material similar materiality

This filing

Article 3 of the bylaws has been amended to change the location of the registered office of the Company to 107, avenue de la République, 92320 Châtillon, France.

Comparable filing

At the extraordinary general meeting of Silexion Therapeutics Corp (the “ Company ”) originally held on April 28, 2026 and reconvened on May 5, 2026 (the “ Meeting ”), the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company’s authorized share capital, as described in Item 5.07 below.

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-24-140531
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.